Home → Research News → Ask-the-Expert Conferences: Research News → June 2008: Updates from the 2008 ASCO Annual Meeting → Big, positive news presented at ASCO?

Big, positive news presented at ASCO?

Page last modified on: August 20, 2008

Question from Marcello: Doctors, overall did you take away a general sense of positive news and advances from this ASCO meeting, whether the changes and improvements were big or small?: Answers —Carol Kaplan, M.D.: Absolutely. We are excitingly moving into an era of treating patients in a more targeted manner. Breast cancer research is moving away from treating a broad range of breast cancer patients with general anti-cancer drugs and moving towards the art of picking an individualized therapy for each subset of breast cancer, whether it be ER or PR positive or HER2 positive or associated with the BRCA mutations. Each year at ASCO, we find we're hearing yet another way to allow women to be survivors after breast cancer.; Generosa Grana, M.D., F.A.C.P.: I would absolutely agree with that. It is an incredibly exciting time to be taking care of women with breast cancer. Metastatic disease is being approached more as a chronic disease and many of the exciting findings from advanced cancer are being moved to the early-stage setting where they are likely to have a greater impact on survival. The future holds tremendous promise for breast cancer patients.

On Wednesday, June 18, 2008 our Ask-the-Expert Online Conference was called Updates from the 2008 ASCO Annual Meeting. Generosa Grana, M.D., F.A.C.P. and Carol Kaplan, M.D. answered your questions about the latest research advances on screening, treatment, side effects, and more.

The materials presented in these conferences do not necessarily reflect the views of breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2008. All rights reserved.

Email Updates

Stay informed about current research, online events, and more.

Meet the Experts

Generosa Grana, M.D., F.A.C.P. is the director of the Cooper Cancer Institute and heads the division of hematology/medical oncology at Cooper University Hospital.

Carol Kaplan, M.D. is an assistant professor of clinical medicine in the Rena Rowan Breast Center at the Hospital of the University of Pennsylvania. Her work revolves around the clinical care of breast cancer patients, as well as teaching medical students and house staff.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

View Mobile Site